1351815-41-2

Upstream product

• 1351815-40-1 [2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)phenyl][4-(hydroxymethyl)piperidin-1-yl]methanone 
• 540527-11-5 methyl 4-acetoxy-2-hydroxybenzoate 
• 912545-09-6 2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)benzoic acid 
• 912545-08-5 2,4-bis-benzyloxy-5-isopropenyl-benzoic acid methyl ester 
• 912545-07-4 5-acetyl-2,4-bis(benzyloxy)benzoic acid methyl ester 
• 6883-54-1 5-acetyl-2,4-dihydroxy-benzoic acid methyl ester 
• 2150-47-2 methyl 2,4-dihydroxybenzoate 
• 100-39-0 benzyl bromide 

Downstream Products

• 1351815-56-9 cyclopentyl N-[(1-{[2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)phenyl]carbonyl}piperidin-4-yl)methyl]-L-leucinate 
• 1351815-80-9 C₄₄H₅₉N₃O₅ 
• 1351814-19-1 cyclopentyl N-[(1-{[2,4-dihydroxy-5-(propan-2-yl)phenyl]carbonyl}piperidin-4-yl)methyl]-L-leucinate 

Relevant academic research and scientific papers

BENZAMIDE DERIVATIVES AND THEIR USE AS HSP90 INHIBTORS

The invention provides a compound which is (a) a phenylamide derivative of formula (I) or a tautomer thereof, or (b) a pharmaceutically acceptable salt, N-oxide, hydrate, prodrug or solvate thereof: wherein R1, R2, R3, R4, R5, R6 and R7 are as defined herein. The compounds are useful in the treatment of diseases mediated by HSP90.